eVisit to highlight the enhanced telehealth capabilities resulting from this collaboration during presentation at HIMSS22 Booth #1909.
PHOENIX, Ariz., March 14, 2022 — eVisit, the leading enterprise care delivery platform built for modern health systems and hospitals, today announced a collaboration with Infermedica, a health AI company that improves the symptom assessment and triaging processes, that will embed Infermedica API into eVisit’s Virtual Care Platform. The move will enhance the efficiency of telehealth providers by enabling front-end, early symptom assessment to help guide patients to the right care at the right place.
“eVisit plans to reduce the burden on providers with an efficient, end-to-end platform. We will integrate the most advanced medical API into our system. Adding a symptom checker to the front-end of the eVisit care delivery platform ensures providers are able to assess patient symptoms ahead of a visit, which lowers costs, improves access to care, cuts back on unnecessary ED visits and reduces spread of infections,” said Juli Stover, Chief Strategy Officer of eVisit. “Providers don’t need to invest in several point solutions. The eVisit care delivery platform is designed to support their care delivery needs, from symptom assessment, intake, scheduling, waiting room management, the virtual visit itself, all the way to prescription, discharge, and payment.”
The core function of any symptom checker is to perform a preliminary symptom assessment of patients and generate a recommended triage level. The ability to assess the patient’s condition ahead of a visit allows providers to offer personalized health services. This includes options such as text to chat, video visits for non-urgent cases, or in-person visit recommendations. It also enables prescription refills or mental health support that must be provided on the same day.
Another significant benefit to having a symptom checker at the digital front door is the ability to view the data provided in the application ahead of the visit. Additionally, this data can be integrated with EHRs, therefore reducing the amount of information providers need to key into their EHRs, saving them time. This capability also allows providers to refer to the initial evidence on a patient’s health data to order additional tests prior to a consultation, improving preparation and enhancing the patient interaction.
“Virtual care is here to stay and delivering the best digital experience possible will be vital to ensuring patient loyalty,” says Piotr Orzechowski, Founder and CEO of Infermedica. “This point is made clear in a 2020 study by Accenture where 26% of Americans said they would be willing to change their health provider in exchange for a better digital experience. Since its inception, eVisit has been the leader at helping health providers harness the power of virtual tools to facilitate hybrid care delivery. The addition of our medical API reinforces this approach, optimizing a provider’s ability to quickly assess patients and navigate them to the most appropriate point of care.”
The impact of a symptom checker on the care delivery process is clearly illustrated in Infermedica’s Symptomate Survey. The survey found that 20% of respondents who required medical consultation qualified to use telemedicine instead of an in-person visit. Furthermore, in a group planning to go to the ED prior to using a symptom check, 12.8% decided to consult with a physician first and 5.1% stayed at home after using the tool. Among those who intended to seek medical consultation, 7% stayed at home and self-cared as advised by the symptom checker. Symptom checkers help patients safely avoid unnecessary trips to the ED since they are programmed based on expert guidance and input from many medical professionals and thousands of evidence-based medical concepts.
These modest shifts in care delivery approach can result in significant returns for providers.
The integration of the Infermedica API continues eVisit’s evolution to become the market-defining care delivery platform regardless of where and how care is provided. The company’s mission is to give patients immediate access to care via a variety of entry points – whether that’s a phone call, web search, or visit to an Urgent Care facility – and allow providers to evaluate patients (with support from data analysis and symptom checkers) and quickly navigate them to the most appropriate point of care based on the symptoms they are experiencing.
eVisit will detail its collaboration with Infermedica and the capabilities the medical API will add to its platform during a special presentation at HIMSS22.
To learn more, mark your calendar for:
“Care Navigation: Getting Patients to The Front Door”
Presenter: Dave Lovecchio, Product Manager, eVisit
1:30 pm ET on March 15 and 16, 2022
eVisit is the only end-to-end, fully integrated, enterprise care delivery platform built for health systems and hospitals. It delivers innovative consumer experiences in care navigation, care delivery, and care engagement, improving margins at scale without sacrificing quality. eVisit works seamlessly across enterprise service lines and departments to improve outcomes, reduce costs, and boost revenue. Based in Phoenix, Ariz., eVisit helps healthcare organizations, including the largest systems in the U.S., innovate and succeed in today’s changing healthcare market. eVisit is the only Leader in the Forrester Wave™: Virtual Care Platforms in Digital Health, Q1 2021, and is a Representative Vendor in the Gartner® 2020 Market Guide for Virtual Care. Get your complimentary copy of the Forrester Report here and the Gartner Report here. For more information, visit evisit.com.
Infermedica is a leading digital health company, specializing in AI-powered solutions for symptom analysis and patient triage. The company’s mission is to make healthcare accessible, convenient and affordable for everyone worldwide, by automating primary care, from symptom to outcome. Infermedica has been adeptly interweaving medical and technical expertise into their technologies since 2012, to support industry leaders including Loyal, Allianz, Global Excel, Gothaer, Microsoft, and Sana Kliniken. Infermedica is currently being used in more than 30 countries, in 20 languages, and has completed more than 10 million successful health checks to date. To learn more, visit www.infermedica.com
eVisit Media Contact:
Don McCormick: 515-418-1053